Jones; A. Brian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jones; A. Brian.The latest application filed is for "2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulating the function of the vanilloid -1 receptor (vr1)".

Company Profile

0.11.13

Jones; A. Brian - Needham MA
Jones; A. Brian - Clavering GB
Jones; A. Brian - Saffron Walden GB
Jones; A. Brian -
Jones; A. Brian - Walden GB
Jones; A. Brian - Harlow GB
Jones, A. Brian - Arkesden UA
Jones, A Brian - Rahway NJ
Jones; A. Brian - Scotch Plains NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2,3-Substituted fused bicyclic pyrimidin-4(3H)-ones which modulating the function of the vanilloid -1 receptor (VR1) App 20090233947 - Bayliss; Tracy ; et al.	2009-09-17
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders Grant 7,495,020 - Adams , et al. February 24, 2	2009-02-24
Amino-heterocycles as VR-1 antagonists for treating pain Grant 7,442,701 - Blurton , et al. October 28, 2	2008-10-28
Substituted-1-phthalazinamines as vr-1 antagonists Grant 7,329,659 - Blurton , et al. February 12, 2	2008-02-12
Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain Grant 7,285,563 - Brown , et al. October 23, 2	2007-10-23
Therapeutic compounds for treating dyslipidemic conditions Grant 7,125,865 - Jones , et al. October 24, 2	2006-10-24
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders Grant 7,091,230 - Adams , et al. August 15, 2	2006-08-15
Substituted amino heterocycles as vr-1 antagonists for treating pain App 20060154930 - Brown; Rebecca Elizabeth ; et al.	2006-07-13
2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders App 20060122242 - Adams; Alan D. ; et al.	2006-06-08
Amino-heterocycles as vr-1 antagonists for treating pain App 20060040947 - Blurton; Peter ; et al.	2006-02-23
Therapeutic compounds for treating dyslipidemic conditions App 20050239769 - Jones, A. Brian ; et al.	2005-10-27
Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain App 20050197342 - Hollingworth, Gregory John ; et al.	2005-09-08
Therapeutic compounds for treating dyslipidemic conditions Grant 6,908,934 - Adams , et al. June 21, 2	2005-06-21
Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain App 20050107388 - Brown, Rebecca Elizabeth ; et al.	2005-05-19
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders Grant 6,852,738 - Jones , et al. February 8, 2	2005-02-08
Therapeutic compounds for treating dyslipidemic conditions App 20050014807 - Adams, Alan D ; et al.	2005-01-20
Therapeutic compounds for treating dyslipidemic conditions App 20040266849 - Adams, Alan D ; et al.	2004-12-30
2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders App 20040092596 - Adams, Alan D. ; et al.	2004-05-13
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders App 20040073037 - Jones, A. Brian ; et al.	2004-04-15
Therapeutic compounds for treating dyslipidemic conditions App 20030125357 - Adams, Alan D. ; et al.	2003-07-03
Aryloxyacetic acids for diabetes and lipid disorders Grant 6,569,879 - Liu , et al. May 27, 2	2003-05-27
Aryloxyacetic acids for diabetes and lipid disorders App 20020173663 - Liu, Kun ; et al.	2002-11-21
Inhibitors of peptide binding to MHO class II proteins Grant 5,817,757 - Adams , et al. October 6, 1	1998-10-06
Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins Grant 5,719,296 - Acton, III , et al. February 17, 1	1998-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.